Pyroptosis: Role and Mechanisms in Cardiovascular Disease

Xinzhe Chen1, Peng-Chao Tian2, Kai Wang1

  • 1Institute of Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, China.

Insights

Pyroptosis, a novel cell death form, significantly contributes to cardiovascular disease (CVD) by amplifying inflammation and increasing damage. Targeting cardiomyocyte pyroptosis offers a promising therapeutic strategy for CVD treatment.

Area of Science:

  • Cardiovascular Science
  • Cellular Biology
  • Pathology

Background:

  • Cardiovascular disease (CVD) is a leading global cause of mortality, characterized by irreversible cardiac damage and limited regeneration.
  • Cardiomyocyte death, including apoptosis and necrosis, is central to CVD pathogenesis.
  • Pyroptosis, a newly identified inflammatory cell death pathway, is increasingly recognized for its significant role in CVD.

Purpose of the Study:

  • To review the characteristics, mechanisms, and regulation of pyroptosis.
  • To elucidate the role and specific mechanisms of pyroptosis in various cardiovascular diseases.
  • To highlight the therapeutic potential of controlling cardiomyocyte pyroptosis in CVD.

Main Methods:

  • Literature review and synthesis of existing research on pyroptosis.
  • Analysis of the molecular mechanisms underlying pyroptosis in cardiomyocytes.
  • Examination of pyroptosis's involvement in specific CVD models like atherosclerosis and myocardial infarction.

Main Results:

  • Pyroptosis is an inflammatory cell death pathway that exacerbates CVD by promoting inflammation and increasing infarct size.
  • Specific molecular pathways regulating pyroptosis in cardiomyocytes have been identified.
  • Pyroptosis contributes to the pathogenesis of atherosclerosis, myocardial infarction, arrhythmia, and cardiac hypertrophy.

Conclusions:

  • Pyroptosis is a critical mediator in the development and progression of cardiovascular diseases.
  • Understanding pyroptosis mechanisms provides novel therapeutic targets for CVD.
  • Inhibition of cardiomyocyte pyroptosis presents a promising strategy for managing CVD and improving cardiac function.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
48
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
302
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
41
Inflammation01:38

Inflammation

Overview
55.5K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.9K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
84